Specific clinical features define HLA-A∗32:01-positive vancomycin drug reaction with eosinophilia and systemic

Matthew S Krantz1, Chantal Lemoine2, Li Zhou3

  • 1Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tenn; Center for Drug Safety and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.

Abstract

No abstract available in PubMed .